With respect to the relevance of Tregs as mediators of immunosuppression in the clinical setting, Pang et al. investigated the relationships between the expression of HMGB1 and biomarkers of the presence and activity of Tregs in biopsies (n = 100) from patients with cancer of the cervix [136]. The gene discussed is HMGB1; the disease is cervical cancer.